Tegretol 100mg/5ml Oral Suspension

  • DHPC
Company
Novartis Ireland Limited
Active Ingredient
Dosage Form
Oral suspension
Legal Category
B - prescription, may be renewed
Date of revision
10/2026

*further information is available on request to the holder of the authorisation or in the SPC

Direct Healthcare Professional Communications

  • DHPC communication - restriction of use in neonates as concentration of the excipient, propylene glycol, exceeds recommended threshold

    Direct Healthcare Professional Communication (DHPC)

    PDF274.59 KB

Novartis Ireland Limited

Termini 3 Arkle Road Sandyford Dublin 18, D18 C9C5 Dublin

Email
medinfo.dublin@novartis.com